The serum of 100 patients with myasthenia gravis and 441 of their first-degree relatives was studied for the presence of autoantibodies against several antigens. Antibodies to skeletal muscle were present in 22% of the patients and in 2% of the relatives. Both these frequencies were significantly higher than those in matched control subjects. Also, antinuclear antibodies were present more often both in the patients and in the relatives. Typing for HL-A antigens had shown a positive correlation between HL-A 8 and myasthenia gravis which was significantly higher in women than in men. Antibodies to skeletal muscle and thymomas were found to be much rarer in HL-A 8-positive patients than in HL-A 8-negative patients; HL-A 8-positive patients acquired the disease at an earlier age.
Introduction
Though there are some indications that myasthenia gravis occurs in families more often than can be explained by probability, definite conclusions about the role of heredity have been hampered by the low prevalence of the disease (Herrmann, 1971) . Wright and Kerr (1967) found no antibodies to skeletal muscle in 86 first-degree relatives of 32 patients. Bundey et al. (1972) found these antibodies in 20 out of 149 first-degree relatives of 54 patients with juvenile myasthenia gravis. However, this figure was not significantly higher than that found in their control group. Van den Berg-Loonen et al. (1974) showed that people heterozygous for the histocompatibility antigen HL-A 8 have a five times greater chance of acquiring myasthenia gravis than those without the antigen, this chance being 25 times increased for homozygous persons. This paper reports some results of a study of 100 patients with myasthenia gravis. The prevalence of antibodies to several autologous antigens was determined in the patienits, 441 of their first-degree relatives, and 39 spouses. Furthermore, it was investigated whether the correlation of myasthenia gravis with antigens of the HL-A system, found in the group of patients as a whole (Feltkamp et al., 1974; Van den Berg-Loonen et al., 1974) (Lucas et al., 1972; Feltkamp, 1974 (Doniach and Roitt, 1964) , no mutual relation between the presence of autoantibodies of other specificities was found. The mean age of the 22 patients with antibodies to skeletal muscle was 52 years, that of the 13 patients with a thymoma was 50 years. Since the mean age of 77 patients without antibodies to skeletal muscle or a proved thymoma was only 38 years it was not clear whether the discrepant HL-A 8 and HL-A 2 distribution was linked to age or to the presence of autoantibodies or of a thymoma. Even in patients aged 40 or over without antibodies to skeletal muscle or a proved thymoma, however, HL-A 8 was present in only two out of the nine cases, in contrast to 27 out of 32 such patients aged under 40 (P <0 01). HL-A 2 was found in seven of these patients aged 40 or over and in only 10 aged u der 40 (P <0 01). Since age at the time of study could be biased by several factors we also examined the possible relation between HL-A 8 and HL-A 2 prevalencies and the age of the patient at the onset of the disease (table III) . This table shows that HL-A 8 is significantly more prevalent in patients in whom the disease began under the age of 40 years (P <0 001) and that HL-A 2 is significantly more prevalent in patients in whom the disease started after that age (P <0 02). The question whether the patients with autoantibodies other than those to skeletal muscle showed a prevalence for certain HL-A antigens was also studied. The results (table IV) Because in the whole group of patients significant deviations from the normal prevalence of HL-A antigens were found to be secondary to the greatly increased prevalence of HL-A 8 the possibility that the deviations might also be secondary to the abnormal prevalence of HL-A 8 had to be investigated (Van den Berg-Loonen et al., 1974) . We therefore looked to see whether the same relations were found if the X2 calculations were corrected for the effect of the excess of HL-A 8 (Aird et al., 1954) . A homogeneity of the distribution of HL-A 7 over the sexes was then still improbable (P <0 1). The same was found for HL-A 2 in patients with antibodies to skeletal muscle (P <0 1), with a thymoma (P <0 1), an age of 40 years or over (P <0 2), or an onset of the disease above that age (P <0 1), as well as for the relation between W 10 and antibodies to gastric parietal cells (P <0 1). The relations between the presence of antinuclear antibodies and the histocompatibility antigens HL-A 13, W 14, and W 15 (P <0 01) were not changed by such a correction procedure.
Discussion
Owing to the large number studied in the present investigation it was possible for the first time to show significantly increased prevalence of antibodies to skeletal muscle in first-degree relatives of myasthenia gravis patients. The correlation found between HL-A 8 and myasthenia gravis already pointed to the importance of the genetic constitution for the development of this disease (Pirskainen et al., 1972; Van den Berg-Loonen et al., 1974; Feltkamp et al., 1974) . The HL-A 8 influence is probably present mainly in women, since the occurrence of this antigen is significantly higher in female than in male patients.
It is striking that in patients with autoimmune phenomenathat is, antibodies to skeletal muscle or a thymoma or both-the prevalence of HL-A 8 was less, and that of HL-A 2 more than in patients lacking such phenomena. It might therefore be supposed that two forms of myasthenia gravis exist. Firstly, a form which develops especially in women who often have the HL-A 8 antigen, acquire the disease at an early age, and have no antibodies to skeletal muscle and no thymoma. Secondly, a form present in persons in whom HL-A 8 is less prevalent, in whom the onset of the disease is much later, and in whom antibodies to skeletal muscle and a thymoma are found. The HL-A 2 frequency in the second group of patients is much higher than in the first.
With respect to the observation by Kissmeyer-Nielsen et al. (1971) that HL-A 8 and HL-A 1 are associated with an increased transplant rejection, which probably indicates a sensitive immune system, it is significant that the myasthenia gravis patients with autoantibodies and a thymoma showed a normal prevalence of HL-A 8.
Idiopathic autoimmune diseases are possibly caused by viral infections (Van Loghem, 1973) . The presence of certain HL-A antigens is also supposed to be linked to the degree of susceptibility to certain viral infections, either by providing a cellmembrane receptor site for viruses, or by an antigenic resemblance of certain viral and host cell-membrane antigens leading to a tolerance for the viral antigens (McDevitt and Bodmer, 1972) . The concept of two forms of myasthenia gravis does not help to solve the problem of a supposed viral aetiology. HL-A antigens are cell-membrane antigens, and myasthenia gravis is characterized by an impaired neuromuscular transmission. A certain genetic-determined cell-membrane composition may therefore be especially liable to quantitative shortcomings of neuromuscular transmitters. This proposition might stimulate further studies on the distribution of HL-A antigens present on the synapse and muscular end-plate membranes. The autoimmune traits of myasthenia gravis may be mere epiphenomena (Feltkamp, 1974) . We hope that the new arguments for genetic factors being involved in the aetiology of myasthenia gravis may lead to a better understanding of the pathogenesis.
